These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 25227663

  • 1. Prognostic significance of BRCA1, ERCC1, RRM1, and RRM2 in patients with advanced non-small cell lung cancer receiving chemotherapy.
    Zhao H, Zhang H, Du Y, Gu X.
    Tumour Biol; 2014 Dec; 35(12):12679-88. PubMed ID: 25227663
    [Abstract] [Full Text] [Related]

  • 2. ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer.
    Su C, Zhou S, Zhang L, Ren S, Xu J, Zhang J, Lv M, Zhang J, Zhou C.
    Med Oncol; 2011 Dec; 28(4):1411-7. PubMed ID: 20467918
    [Abstract] [Full Text] [Related]

  • 3. Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients.
    Boukovinas I, Papadaki C, Mendez P, Taron M, Mavroudis D, Koutsopoulos A, Sanchez-Ronco M, Sanchez JJ, Trypaki M, Staphopoulos E, Georgoulias V, Rosell R, Souglakos J.
    PLoS One; 2008 Dec; 3(11):e3695. PubMed ID: 19002265
    [Abstract] [Full Text] [Related]

  • 4. RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer.
    Zhang GB, Chen J, Wang LR, Li J, Li MW, Xu N, Wang Y, Shentu JZ.
    Cancer Chemother Pharmacol; 2012 May; 69(5):1277-87. PubMed ID: 22302408
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy.
    Leng XF, Chen MW, Xian L, Dai L, Ma GY, Li MH.
    J Exp Clin Cancer Res; 2012 Mar 23; 31(1):25. PubMed ID: 22439756
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ERCC1 mRNA expression is associated with the clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy.
    Zhang H, Li J, Zhang Y, Sun M, Zhao P, Zhang G, Jin C, Sun L, He M, Wang B, Zhang X.
    Genet Mol Res; 2014 Dec 04; 13(4):10215-22. PubMed ID: 25501233
    [Abstract] [Full Text] [Related]

  • 11. Expression of RRM1 and RRM2 as a novel prognostic marker in advanced non-small cell lung cancer receiving chemotherapy.
    Wang L, Meng L, Wang XW, Ma GY, Chen JH.
    Tumour Biol; 2014 Mar 04; 35(3):1899-906. PubMed ID: 24155212
    [Abstract] [Full Text] [Related]

  • 12. A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer.
    Heo SJ, Jung I, Lee CK, Kim JH, Lim SM, Moon YW, Shim HS, Jeong J, Kim JH, Kim HR, Cho BC.
    Cancer Chemother Pharmacol; 2016 Mar 04; 77(3):539-48. PubMed ID: 26811178
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients.
    Mlak R, Krawczyk P, Ramlau R, Kalinka-Warzocha E, Wasylecka-Morawiec M, Wojas-Krawczyk K, Kucharczyk T, Homa I, Kozioł P, Ciesielka M, Chudziak D, Milanowski J.
    Oncol Rep; 2013 Nov 04; 30(5):2385-98. PubMed ID: 23982437
    [Abstract] [Full Text] [Related]

  • 14. Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance.
    Zhang Q, Sun T, Kang P, Qian K, Deng B, Zhou J, Wang R, Jiang B, Li K, Liu F, Wu S, Tan Q.
    Cancer Chemother Pharmacol; 2016 Mar 04; 77(3):583-93. PubMed ID: 26842788
    [Abstract] [Full Text] [Related]

  • 15. First-line gemcitabine plus cisplatin in nonsmall cell lung cancer patients.
    Li Y, Wang LR, Chen J, Lou Y, Zhang GB.
    Dis Markers; 2014 Mar 04; 2014():960458. PubMed ID: 24591771
    [Abstract] [Full Text] [Related]

  • 16. mRNA expression and clinical significance of ERCC1, BRCA1, RRM1, TYMS and TUBB3 in postoperative patients with non-small cell lung cancer.
    Han Y, Wang XB, Xiao N, Liu ZD.
    Asian Pac J Cancer Prev; 2013 Mar 04; 14(5):2987-90. PubMed ID: 23803067
    [Abstract] [Full Text] [Related]

  • 17. RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC.
    Vilmar A, Garcia-Foncillas J, Huarriz M, Santoni-Rugiu E, Sorensen JB.
    Lung Cancer; 2012 Mar 04; 75(3):306-12. PubMed ID: 21996087
    [Abstract] [Full Text] [Related]

  • 18. Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I-III Non-Small Cell Lung Cancer.
    Grossi F, Dal Bello MG, Salvi S, Puzone R, Pfeffer U, Fontana V, Alama A, Rijavec E, Barletta G, Genova C, Sini C, Ratto GB, Taviani M, Truini M, Merlo DF.
    Dis Markers; 2015 Mar 04; 2015():302649. PubMed ID: 26663950
    [Abstract] [Full Text] [Related]

  • 19. Predictive role of RRM1 and BRCA1 mRNA expression on the clinical outcome of advanced non-small cell lung cancer.
    Liang JG, Jin ZY, Gao XD, Te MR, Ge LH, Wang CL.
    Genet Mol Res; 2014 Jul 24; 13(3):5292-8. PubMed ID: 25078585
    [Abstract] [Full Text] [Related]

  • 20. Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery.
    Rosell R, Felip E, Taron M, Majo J, Mendez P, Sanchez-Ronco M, Queralt C, Sanchez JJ, Maestre J.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 2):4215s-4219s. PubMed ID: 15217961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.